Mylan (MYL) announced Wednesday morning that it has received approval from the FDA for Glatiramer Acetate Injection 40 mg/mL for 3-times-a-week injection. The drug is a generic version of Teva's (TEVA) Copaxone, for patients with relapsing forms of multiple sclerosis.
from RTT - Before the Bell http://ift.tt/2hOtgwo
via IFTTT
No comments:
Post a Comment